Response-Guided Neoadjuvant Chemotherapy for Breast Cancer

von Minckwitz, Gϋnter; Blohmer, Jens‐Uwe; Dan Costa, Serban; Denkert, Carsten; Eidtmann, Holger; Eiermann, W.; Gerber, Bernd; Hanusch, Claus; Hilfrich, J.; Huober, Jens; Jackisch, Christian; Kaufmann, Manfred; Kümmel, Sherko; Paepke, Stefan; Schneeweiß, Andreas; Untch, Michael; M. Zahm, Dirk; Mehta, Keyur; Loibl, Sibylle

doi:10.1200/jco.2012.45.0940

Public

Response-Guided Neoadjuvant Chemotherapy for Breast Cancer

Published in Journal of Clinical Oncology • Sep 4, 2013

Authors:

Gϋnter von Minckwitz

Jens‐Uwe Blohmer

Serban Dan Costa

Abstract

PURPOSE: We investigated disease-free survival (DFS) and overall survival (OS) after response-guided neoadjuvant chemotherapy in patients with early breast cancer. PATIENTS AND METHODS: We treated 2,072 patients with two cycles of docetaxel, doxorubicin, and cyclophosphamide (TAC) and randomly assig...

Subject

Medicine

Docetaxel

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!